Moshe Fridman Selected Research

Moshe Fridman Research Topics

Disease

7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2017 - 12/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2007 - 05/2002
5	Anemia 02/2012 - 08/2002
4	Febrile Neutropenia 12/2003 - 05/2002
3	Postpartum Depression (Post-Natal Depression) 01/2021 - 10/2020
3	Hereditary Angioedemas 01/2020 - 03/2017
2	Weight Loss (Weight Reduction) 01/2020 - 06/2019
2	Cystic Fibrosis (Mucoviscidosis) 12/2019 - 08/2019
2	Type 2 Diabetes Mellitus (MODY) 06/2019 - 06/2019
2	Infections 03/2013 - 03/2007
2	Alzheimer Disease (Alzheimer's Disease) 07/2011 - 11/2010
2	Neutropenia 05/2006 - 07/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2006 - 12/2003
2	Hypoalbuminemia 05/2006 - 12/2002
2	Breast Neoplasms (Breast Cancer) 01/2004 - 07/2003
1	Thrombosis (Thrombus) 01/2021
1	Pulmonary Embolism 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Pain (Aches) 04/2018
1	Hyperphosphatemia 01/2014
1	Hemorrhage 03/2013
1	Uterine Rupture 02/2012
1	Abruptio Placentae (Placental Abruption) 02/2012
1	Needlestick Injuries (Needlestick Injury) 08/2011
1	Atrophy 07/2011
1	Lymphoma (Lymphomas) 05/2006
1	Pyelonephritis 03/2006
1	Carcinoma (Carcinomatosis) 11/2005
1	Malnutrition (Nutritional Deficiencies) 12/2002
1	Kidney Diseases (Kidney Disease) 12/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2002
1	Neoplasms (Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2007 - 03/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2007 - 03/2003
5	Vincristine (Oncovin)FDA LinkGeneric 03/2007 - 03/2003
5	Filgrastim (Neupogen)FDA Link 03/2007 - 03/2003
5	Prednisone (Sone)FDA LinkGeneric 03/2007 - 03/2003
3	Hemoglobins (Hemoglobin)IBA 01/2004 - 08/2002
2	brexanoloneIBA 01/2021 - 10/2020
2	Tuberculin (PPD)IBA 01/2021 - 01/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 06/2019
2	Indicators and Reagents (Reagents)IBA 03/2013 - 03/2006
2	Memantine (Namenda)FDA Link 07/2011 - 11/2010
2	Rituximab (Mabthera)FDA Link 03/2007 - 05/2006
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2006 - 08/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2006 - 12/2003
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2003 - 05/2002
1	baricitinibIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	ruxolitinibIBA 01/2021
1	tofacitinibIBA 01/2021
1	Pregnanolone (Allopregnanolone)IBA 10/2020
1	NeurosteroidsIBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	ivacaftorIBA 08/2019
1	Opiate AlkaloidsIBA 04/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2018
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 03/2017
1	Guanfacine (Tenex)FDA LinkGeneric 03/2017
1	ORALIT (ORS)IBA 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 08/2016
1	2-toluenesulfonamide (OTS)IBA 03/2015
1	Lisdexamfetamine Dimesylate FDA Link 02/2015
1	Methylphenidate (Ritalin)FDA LinkGeneric 02/2015
1	Phosphates (Orthophosphate)IBA 01/2014
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2005
1	Docetaxel (Taxotere)FDA Link 11/2005
1	Epoetin Alfa (Epogen)FDA Link 01/2004

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2017 - 08/2002
10	Therapeutics 01/2020 - 08/2002
2	Glycemic Control 01/2020 - 06/2019
1	Injections 06/2019
1	Diet Therapy (Therapy, Diet) 01/2014
1	Patient Discharge 03/2013
1	Hysterectomy 02/2012
1	Nursing Care 08/2011
1	Home Nursing (Nursing, Home) 11/2010
1	Ambulatory Care (Outpatient Care) 03/2006
1	Blood Transfusion (Blood Transfusions) 01/2004
1	Adjuvant Chemotherapy 07/2003
1	Renal Dialysis (Hemodialysis) 12/2002
1	Length of Stay 05/2002